The BCG Moreau RD16 deletion inactivates a repressor reshaping transcription of an adjacent gene.

Tuberculosis (Edinb)

Laboratório de Genômica Funcional e Bioinformática, Instituto Oswaldo Cruz, Fiocruz. Av. Brasil 4365, Manguinhos, 21040-900 Rio de Janeiro, RJ, Brazil. Electronic address:

Published: January 2014

The Brazilian anti-tuberculosis vaccine strain Mycobacterium bovis bacillus Calmette-Guérin (BCG) BCG Moreau is unique in having a deletion of 7608 bp (RD16) that results in the truncation of a putative TetR transcriptional regulator, the ortholog of Mycobacterium tuberculosis rv3405c, BCG_M3439c. We investigated the effect of this truncation on the expression of the rv3406 ortholog (BCG_M3440), lying 81 bp downstream in the opposite orientation. RT-PCR and western blot experiments show that rv3406 mRNA and Rv3406 accumulate in BCG Moreau but not in BCG Pasteur (strain that bears an intact rv3405c), suggesting this to be a result of rv3405c truncation. Recombinant Rv3405c forms a complex with the rv3405c-rv3406 intergenic region, which contains a characteristic transcription factor binding site, showing it to have DNA binding activity. Complementation of M. bovis BCG Moreau with an intact copy of rv3405c abolishes Rv3406 accumulation. These results show that Rv3405c is a DNA binding protein that acts as a transcriptional repressor of rv3406.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tube.2013.11.004DOI Listing

Publication Analysis

Top Keywords

bcg moreau
16
dna binding
8
bcg
6
rv3405c
6
rv3406
5
moreau rd16
4
rd16 deletion
4
deletion inactivates
4
inactivates repressor
4
repressor reshaping
4

Similar Publications

Functional impact of a deletion in Mycobacterium bovis BCG Moreau celA1 gene.

Tuberculosis (Edinb)

December 2024

Laboratório de Genômica Funcional e Bioinformática, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil. Electronic address:

Several mycobacterial species are known to cause human diseases, such as tuberculosis and leprosy. In addition to these pathogenic species, there are also saprophytic representatives, which occasionally cause opportunistic infections. It is well established that numerous mycobacteria produce biofilms containing cellulose, and their genomes frequently harbor genes involved in cellulose degradation, such as celA1.

View Article and Find Full Text PDF

Introduction: Bacillus Calmette-Guerin (BCG) Moreau is under-represented in literature and comparisons with other BCG strains are rare.

Material And Methods: We conducted a retrospective data analysis in patients with intermediate or high-risk non-muscle invasive bladder cancer (NMIBC) to assess effectiveness and safety of BCG Moreau Polish substrain to BCG RIVM. The primary objective was to describe the real-world effectiveness of BCG Moreau in the treatment of patients with NMIBC in terms of recurrence free survival (RFS) 2 years post-treatment initiation compared to BCG RIVM.

View Article and Find Full Text PDF

Unlabelled: Currently, tuberculosis immunoprophylaxis is based solely on Bacillus Calmette-Guérin (BCG) vaccination, and some of the new potential tuberculosis vaccines are based on the BCG genome. Therefore, it is reasonable to analyze the genomes of individual BCG substrains. The aim of this study was the genetic characterization of the BCG-Moreau Polish (PL) strain used for the production of the BCG vaccine in Poland since 1955.

View Article and Find Full Text PDF

Transcriptional Profiling of Homologous Recombination Pathway Genes in BCG Moreau.

Microorganisms

October 2023

Laboratório de Biologia Molecular Aplicada à Micobactérias, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-900, RJ, Brazil.

BCG Moreau is the main Brazilian strain for vaccination against tuberculosis. It is considered an early strain, more like the original BCG, whereas BCG Pasteur, largely used as a reference, belongs to the late strain clade. BCG Moreau, contrary to Pasteur, is naturally deficient in homologous recombination (HR).

View Article and Find Full Text PDF

Differences in responses to the intracellular macrophage environment between Mycobacterium bovis BCG vaccine strains Moreau and Pasteur.

Mem Inst Oswaldo Cruz

October 2023

Fundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Genômica Funcional e Bioinformática, Rio de Janeiro, RJ, Brasil.

Article Synopsis
  • The BCG vaccine consists of different strains that vary in effectiveness against tuberculosis and leprosy due to their genetic differences.
  • Researchers studied how two BCG strains (Moreau and Pasteur) behave when interacting with macrophages, which are immune cells that respond to infections.
  • Findings revealed that BCG Moreau has a higher survival rate inside macrophages, while BCG Pasteur triggers stronger immune responses, highlighting the distinct advantages of each strain in the context of vaccination.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!